Skip to main content

Together we are beating cancer

Donate now

Cancer News

Research and trials

Showing 12 out of 1701 results
winding road

From obscure enzymes to the common cold… just how did spin out Myricx Bio put their ADC on the path to clinical development? From obscure enzymes to the common cold… just how did spin out Myricx Bio put their ADC on the path to clinical development?

by Phil Prime | In depth | 9 July 2024

9 July 2024

Visitors at the National Biomarker Centre

Today marks the opening of the Cancer Research UK National Biomarker Centre, a new state-of-the-art facility in Manchester which will help experts detect cancer at an earlier stage – when there are usually more treatment options available. Today marks the opening of the Cancer Research UK National Biomarker Centre, a new state-of-the-art facility in Manchester which will help experts detect cancer at an earlier stage – when there are usually more treatment options available.

by Amy Warnock | News | 14 June 2024

14 June 2024

A computer-generated image showing a DNA double-helix in a blood sample

Multi-cancer tests have the potential to detect multiple cancer types from a single sample. There's a lot to learn before we can use them. Multi-cancer tests have the potential to detect multiple cancer types from a single sample. There's a lot to learn before we can use them.

by Jessica Lloyd, Alice Brookes | In depth | 12 June 2024

12 June 2024

This entry is part 1 of 4 in the series Multi-cancer tests
People at a party wearing party hats

In this third and final article in this special series about our PPI project ‘How can we share research together? A co-creation project to make scientific research more accessible’ we hear from one of the patient representatives who took part in the project, Holly Spencer. Here Holly reflects on her diagnosis, her interest in patient and public involvement and her experience of being part of this project. In this third and final article in this special series about our PPI project ‘How can we share research together? A co-creation project to make scientific research more accessible’ we hear from one of the patient representatives who took part in the project, Holly Spencer. Here Holly reflects on her diagnosis, her interest in patient and public involvement and her experience of being part of this project.

by Holly Spencer | Personal stories | 11 June 2024

11 June 2024

This entry is part 3 of 3 in the series How can we share research together?
An informational sheet highlighting how radiotherapy can be used to make radiotherapy in children more precise

A graphic designer shares their perspective on a recent patient and public involvement project during which an accessible information sheet based on a journal paper was co-created A graphic designer shares their perspective on a recent patient and public involvement project during which an accessible information sheet based on a journal paper was co-created

by Gill Brown | Analysis | 4 June 2024

4 June 2024

This entry is part 2 of 3 in the series How can we share research together?
A medical professional drawing a dose of a vaccine from a vial with a syringe

Thousands of cancer patients in England are set to gain fast-tracked access to trials of personalised cancer vaccines following the launch of a world-leading NHS trial ‘matchmaking' service Thousands of cancer patients in England are set to gain fast-tracked access to trials of personalised cancer vaccines following the launch of a world-leading NHS trial ‘matchmaking' service

by Jacob Smith | News | 31 May 2024

31 May 2024

Anna Housley and her husband Tom. The BCAN-RAY project found that Anna has an increased risk of developing breast cancer. She now gets yearly mammograms.

One year in, the research project launched in memory of Sarah Harding is identifying younger women who may have a higher breast cancer risk. One year in, the research project launched in memory of Sarah Harding is identifying younger women who may have a higher breast cancer risk.

by Tim Gunn | News | 30 May 2024

30 May 2024

This entry is part 18 of 37 in the series That Cancer Conversation
An abstract illustration of a DNA molecule

Researchers from the Cancer Grand Challenges Mutographs team have identified a previously unknown mutational signature in the DNA of kidney cancer across 11 countries Researchers from the Cancer Grand Challenges Mutographs team have identified a previously unknown mutational signature in the DNA of kidney cancer across 11 countries

by Jacob Smith | In depth | 1 May 2024

1 May 2024

Vaccine vial and needle

Iain Foulkes, Executive Director of Research and Innovation at Cancer Research UK, reflects on today's news that Moderna and MSD’s melanoma cancer vaccine is moving to Phase 3 clinical trials Iain Foulkes, Executive Director of Research and Innovation at Cancer Research UK, reflects on today's news that Moderna and MSD’s melanoma cancer vaccine is moving to Phase 3 clinical trials

by Iain Foulkes | Opinion | 26 April 2024

26 April 2024